Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 2
1973 12
1974 38
1975 103
1976 189
1977 279
1978 478
1979 588
1980 657
1981 748
1982 726
1983 795
1984 904
1985 897
1986 894
1987 879
1988 841
1989 887
1990 794
1991 758
1992 673
1993 670
1994 669
1995 658
1996 579
1997 517
1998 539
1999 457
2000 420
2001 397
2002 439
2003 378
2004 352
2005 399
2006 344
2007 341
2008 299
2009 310
2010 307
2011 271
2012 273
2013 264
2014 289
2015 232
2016 239
2017 230
2018 177
2019 164
2020 233
2021 247
2022 189
2023 147
2024 156
2025 126
2026 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,807 results

Results by year

Filters applied: . Clear all
Page 1
H2-receptor antagonist non-responders.
Savarino V, Mela GS, Scalabrini P, Celle G. Savarino V, et al. Lancet. 1987 Nov 28;2(8570):1281. doi: 10.1016/s0140-6736(87)91898-8. Lancet. 1987. PMID: 2890898 No abstract available.
The H2-receptor antagonist era in duodenal ulcer disease.
Marks IN. Marks IN. Yale J Biol Med. 1992 Nov-Dec;65(6):639-48;discussion 689-92. Yale J Biol Med. 1992. PMID: 1364125 Free PMC article. Review.
This paper reviews the remarkable impact of H2-receptor antagonists on duodenal ulcer management. The development and the scientific rationale of these agents are presented, and efficacy and safety aspects in the short- and long-term treatment of duodenal ulc …
This paper reviews the remarkable impact of H2-receptor antagonists on duodenal ulcer management. The development and t …
Ranitidine--a new H2-receptor antagonist.
Woodings EP, Dixon GT, Harrison C, Carey P, Richards DA. Woodings EP, et al. Gut. 1980 Mar;21(3):187-91. doi: 10.1136/gut.21.3.187. Gut. 1980. PMID: 6105117 Free PMC article.
The pharmacokinetics and gastric antisecretory effects of a new histamine H2-receptor antagonist, ranitidine hydrochloride, have been investigated in healthy subjects. ...
The pharmacokinetics and gastric antisecretory effects of a new histamine H2-receptor antagonist, ranitidine hyd …
H2-receptor antagonist non-responders.
Chiverton SG, Hunt RH. Chiverton SG, et al. Lancet. 1988 Jul 30;2(8605):275. doi: 10.1016/s0140-6736(88)92559-7. Lancet. 1988. PMID: 2899255 No abstract available.
Reflux esophagitis.
Tytgat GN, Nio CY, Schotborgh RH. Tytgat GN, et al. Scand J Gastroenterol Suppl. 1990;175:1-12. doi: 10.3109/00365529009093121. Scand J Gastroenterol Suppl. 1990. PMID: 1978403 Review.
Single-agent therapy with conventional-dose H2-receptor antagonists or sucralfate results in similar degrees of symptom relief and healing. ...To prolong the symptomatic and/or endoscopic remission, the therapy has to be continued long-term with high-dose …
Single-agent therapy with conventional-dose H2-receptor antagonists or sucralfate results in similar degrees of symptom …
22,807 results
You have reached the last available page of results. Please see the User Guide for more information.